• Odbierz prezent
SOPHARMA AD: Analysis of potential acquisition opportunities on the territory of the Republic of Serbia (2023-06-01 13:45)
fot. freepik.com
POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No26/2023
Date of issue:2023-06-01
Short name of the issuer
SOPHARMA AD
Subject
Analysis of potential acquisition opportunities on the territory of the Republic of Serbia
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that at its meeting the Board of Directors decided to conduct a detailed analysis of potential opportunities for acquisition of shares in the capital of companies engaged in the production and/or marketing of medicinal products, food supplements, medical devices and/or other goods of importance to human health on the territory of the Republic of Serbia. The Board of Directors has authorized the representatives of the Company to carry out all necessary legal and factual actions related to the evaluation, investigation and initial negotiations for the implementation of a possible acquisition of a joint participation and/or a majority stake in the capital of such companies.
Annexes
FileDescription
МА_Serbia_2023_espi_26.pdfAnalysis of potential acquisition opportunities on the territory of the Republic of Serbia
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2023-06-01Ognian DonevExecutive Director

ESPI

ESPI - Komunikaty spółek

Przejdź do artykułów autora
Artykuły, które powinny Cię zaciekawić..
Zamknij

Koszyk